| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology and Genetics, Bilthoven, and 2 Utrecht University, Department of Pathobiology, Utrecht, the Netherlands
Both nucleotide excision repair (NER) and the p53 tumor suppressor protein play crucial roles in the prevention of cells becoming cancerous. This is clearly demonstrated by the fact that NER-deficient xeroderma pigmentosum patients and Li-Fraumeni patients who carry a germ-line p53 mutation are highly tumor prone. The NER-deficient Xpa and the p53+/ mouse models clearly mimic their human counterparts, because they are both tumor prone as well. The aim of the study presented here was to analyze the relative contribution of these two pathways in tumor suppression and to analyze a possible link between NER and p53 activation in vivo. For this, we exposed Xpa, p53+/, and Xpa/p53+/ mice to 2-acetylaminofluorene (2-AAF). We show that 2-AAF-induced urinary bladder tumor suppression is dependent on p53 status, because p53+/ mice were highly tumor prone. Xpa/p53+/ mice were even more tumor prone, whereas no increased tumor response was found in Xpa mice. Short-term assays revealed a decreased apoptotic response in Xpa/p53+/ mice, pointing in vivo toward a link between NER and p53-mediated apoptosis. In contrast, liver tumor response was primarily dependent on appropriate DNA repair, because Xpa-deficient mice were liver tumor prone. p53 heterozygosity had no influence on liver tumor incidences, in line with the results obtained from the short-term 2-AAF studies revealing no altered cellular response in p53+/ or Xpa/p53+/ mice. Interestingly, however, mice completely deficient in both NER and p53 (Xpa/p53/ mice) showed a dramatic increase of hepatocellular proliferation accompanied by lacZ reporter gene mutations.
This article has been cited by other articles:
![]() |
W. Bruins, M. J. Jonker, O. Bruning, J. L.A. Pennings, M. M. Schaap, E. M. Hoogervorst, H. van Steeg, T. M. Breit, and A. de Vries Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation Carcinogenesis, August 1, 2007; 28(8): 1814 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al. Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage Cancer Res., May 15, 2007; 67(10): 4648 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. Zwart, E. N. Speksnijder, R. B. Beems, K. P. Olive, D. A. Tuveson, J. Jonkers, M. M. Schaap, J. van den Berg, T. Jacks, et al. Mice Expressing a Mammary Gland-Specific R270H Mutation in the p53 Tumor Suppressor Gene Mimic Human Breast Cancer Development Cancer Res., September 15, 2005; 65(18): 8166 - 8173. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Hoogervorst, W. Bruins, E. Zwart, C. Th.M. van Oostrom, G. J. van den Aardweg, R. B. Beems, J. van den Berg, T. Jacks, H. van Steeg, and A. de Vries Lack of p53 Ser389 Phosphorylation Predisposes Mice to Develop 2-Acetylaminofluorene-Induced Bladder Tumors but not Ionizing Radiation-Induced Lymphomas Cancer Res., May 1, 2005; 65(9): 3610 - 3616. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |